Sutro Biopharma, a privately owned biotechnology company located in South San Francisco, US, has appointed Nicki Vasquez as Vice President of Alliance and Project Management.
Vasquez takes a leadership role in the management of Sutro's collaborative partnerships and the development of its antibody-drug conjugates, bispecific antibodies and antibody-based therapeutics targeting immuno-oncology pathways.
Vasquez brings more than 22 years of experience in the biopharmaceutical sector with expertise in management of preclinical and clinical therapeutic development; as well as expertise in research operations and programme management. Most recently, she was Vice President of Programme and Portfolio Management at StemCells, where she was responsible for building and driving forward R&D programme management for the company's preclinical and leading Phase II programmes.
Prior to StemCells, Dr Vasquez held several senior positions at Elan (now acquired by Perrigo).
